Two drug companies in Baltimore were found liable for the city's opioid crisis, leading to a $266 million payment split between McKesson and AmerisourceBergen. The trial revealed allegations of prioritizing profit over public health by oversupplying opioids.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing